Analytical Data
-
Gene name
HSMPP8
- Application
-
Alternative Names
HSMPP8; M-phase phosphoprotein 8; M-phase phosphoprotein. mpp; M-phase phosphoprotein. mpp8; MPHOSPH8; MPP8_HUMAN; RP11-523H24.1; Twa3; Two hybrid-associated protein 3 with RanBPM
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q99549
-
Expression Region
1-259aa
-
AA Sequence
MTLVMLAAAGGQDDLLRLLITKGAKVNGRQKNGTTALIHAAEKNFLTTVAILLEAGAFVNVQQSNGETALMKACKRGNSDIVRLVIECGADCNILSKHQNSALHFAKQSNNVLVYDLLKNHLETLSRVAEETIKDYFEARLALLEPVFPIACHRLCEGPDFSTDFNYKPPQNIPEGSGILLFIFHANFLGKEVIARLCGPCSVQAVVLNDKFQLPVFLDSHFVYSFSPVAGPNKLFIRLTEAPSAKVKLLIGAYRVQLQ
-
Molecular Weight
54.8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
HSMPP8, a recombinant protein derived from the human herpesvirus, has garnered significant attention in the field of molecular biology and virology due to its potential applications in vaccine development and therapeutic interventions. The protein is a member of a larger family of viral proteins known for their roles in immune evasion and pathogen-host interactions. Research into HSMPP8 aims to elucidate its structure-function relationships and understand its mechanisms of action in the context of viral infection. Given that herpesviruses are linked to various diseases, including cancers and neurological disorders, the investigation of HSMPP8 could provide insights into the development of novel antiviral strategies. Additionally, studies have shown that recombinant forms of viral proteins can elicit robust immune responses, paving the way for their use as immunogens in vaccine formulations. The ongoing exploration of HSMPP8 is crucial for identifying potential biomarkers for disease progression and developing targeted therapies to enhance host immune responses against viral infections. The multifaceted role of HSMPP8 in the viral life cycle underscores its significance as a research subject, with implications for both basic science and clinical applications.
